Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

KERNX Health vs NovoCare Pharmacy

KERNX Health
Graded #276

Higher grade

vs+7
NovoCare Pharmacy
Graded #442

Lower grade

The verdict

KERNX Health takes it — 62.2/100 to 55.2/100.

KERNX Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Washington DC telehealth platform selling compounded semaglutide and tirzepatide on flat monthly plans, with the physician consultation billed separately per visit.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKERNX Health +38
62
24
Dose & formulationNovoCare Pharmacy +2
64
66
Clinical oversightNovoCare Pharmacy +3
71
74
Labs & monitoringKERNX Health +1
52
51
FulfillmentNovoCare Pharmacy +7
69
76
Contract termsNovoCare Pharmacy +10
45
55
KERNX Health · left barNovoCare Pharmacy · right bar

The numbers

MetricKERNX HealthNovoCare Pharmacy
WeighScore62.2/10055.2/100
GradeCC
Scorecard rank#276#442
Semaglutide$129/mo (promotional rate, plus a separate fee, compounded)$349/mo (2.4 mg dose, brand-name)
Tirzepatide$199/mo (promotional rate, plus a separate fee, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
KERNX Health

Graded #276 · C

Strengths

  • Publishes plan pricing openly, before any intake or account creation
  • Month-to-month with no long-term contract and no multi-month prepayment
  • Billing starts only after a licensed provider approves treatment
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Its own pricing page contradicts itself: it claims no separate consultation charges, then states a $25-$60 fee applies per visit
  • The consultation fee is charged whether or not a prescription is issued
  • Advertised $129 and $199 rates are time-limited founding rates; standard rates are $249 and $299
  • No compounding pharmacy is named anywhere on the site
  • Shipping claims conflict: a 48-hour figure on the homepage against 1-2 days to ship plus 2-3 days transit in the FAQ
NovoCare Pharmacy

Graded #442 · C

Strengths

  • First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
  • $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
  • $349/mo standard self-pay is well below the ~$1,300/mo retail list price
  • Ships to all 50 states with no telehealth-platform middleman fees
  • Cold-chain logistics handled directly by Novo Nordisk

Where it loses points

  • Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
  • Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
  • No clinical support included — your own prescriber handles titration and side effects
  • Manufacturer-set pricing can change at any time
  • $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard